Objective -To determine the characteristics associated with the dropout of patients followed up in a Brazilian out patient clinic specializing in hypertension. 1.78 (1.28-2.48). Age increase was associated with a higher probability of follow-up with a relative risk of 0.98 (0.97-0.99 
Systemic hypertension is an important risk factor for cardiovascular diseases [1] [2] [3] , and it has a high prevalence in the Brazilian adult population. In Porto Alegre, the capital of the State of Rio Grande do Sul in the Southern region of Brazil, approximately 13% of the adults have systemic hypertension 4 . Sustained elevated blood pressure levels are related to a higher incidence of morbid events, are mainly associated with atherosclerosis, and may manifest as ischemic heart disease, cerebral stroke, and renal and peripheral vascular diseases 5, 6 . On the other hand, in several clinical trials [7] [8] [9] , a reduction in fatal and nonfatal cardiovascular events has been associated with the medicamentous treatment of hypertension, mainly with thiazide diuretics and beta-blockers.
In addition, observational studies have shown that most patients with a diagnosis of hypertension have poor adherence to treatment [10] [11] [12] [13] [14] , even though we observe that, in the clinical practice, some patients do not even return for regular medical visits. Fuchs et al 15 have reported a dropout of the regular outpatient clinic follow-up of approximately 45% in a cohort with hypertensive patients.
The objective of this study was to determine the characteristics associated with the dropout of medical followup of patients treated for systemic hypertension, aiming to identify which patients could potentially benefit from the creation of a system of active follow-up.
Methods
The population assessed comprised patients enrolled in the cohort of hypertensive patients undergoing followup in the hypertension unit of the Hospital das Clínicas de Porto Alegre. Patients with a diagnosis of hypertension established after an extensive initial evaluation consisting of anamnesis, complete physical examination, standard complementary examinations (laboratory, electrocardiography at rest, and ophthalmoscopy) and serial measures of blood pressure were included in the study. The classifying blood pressure used for the diagnosis of hypertension was calculated by the mean of 6 measurements obtained in 3 consecutive medical visits, following the technical recommendations established in the international consensus (Sixth Joint National Committee, 1997) 10 . Characteristics of the sample are shown in table I. Those patients who did not have at least 12 months of follow-up were excluded from the study, as were also a few cases of irregular follow-up with a late return to medical visit.
Dropout of medical follow-up was defined as the noshow to follow-up in a period from 12 to 24 months after the initial evaluation. The control group comprised patients who underwent regular follow-up.
The following variables were analyzed: sex, age (≤ or > 60 years), educational level (schooling ≤ or >5 years), duration of disease (time since the first diagnosis of hypertension reported by the patient ≤ or > years), classifying blood pressure (mean of 6 measurements in 3 consecutive medical visits, during the initial evaluation), previous treatment (use of antihypertensive medication in the past or outpatient clinic follow-up already started, under medication), physical activity (regular physical exercise practice), smoking (current, in the past, or never), alcohol (independent from the amount consumed, current, in the past, or never), familial history of hypertension, and lesion in a target organ (repercussion of hypertension in organs, such as the brain, heart, kidneys, retina, and peripheral vessels).
In the statistical analysis, we used the chi-square test and the logistic regression model. We calculated the relative risk for dropping out of the treatment with the respective 95% confidence intervals. The significance established was 5%.
Results
Out of a total of 945 patients studied, 533 (56%) dropped out of follow-up and 412 (44%) remained in regular follow-up for a period of 12 to 24 months. The characteristics of the groups are shown in table II.
In the multivariate analysis carried out with 782 (82.7%) patients, out of all variables studied, 3 were associated in an independent way with a higher probability of dropout, as follows: smoking, schooling <5 years, and hypertension diagnosis for less than <5 years (table III) .
Among current smokers, a dropout rate of 65.5% occurred, while among nonsmokers or ex-smokers the dropout rate was 52.5% (p=0.017). Patients with schooling <5 years also had a higher risk of dropping out of the follow-up, as compared with those patients with a schooling rate >5 years (57.2% vs 52.2%, p=0.025). Hypertensive patients of less than 5 years dropped out of follow-up with a frequency higher than that of those patients with a longer period of disease (60.2% vs 48.6%, p=0.001). The relative risk for dropping out of treatment associated with these characteristics was 1.46 (1.04-2.06) for active smoking, 1.78 (1.11-2.08) for a low schooling rate ( <5 years), and 1.98 (1.28-2.48) for the recent diagnosis of hypertension (<5 years). An increase in age (>60 years) represented a reduction in the risk of dropping out the follow-up with a relative risk of 0.98 (0.97-0.99) (table III) . The remaining characteristics were not significantly associated with the dropout of follow-up.
Discussion
The treatment of hypertension is always based on changes in lifestyle and may or may not be pharmacological. Regardless of he option, the continuous adherence of the patient to the recommended measures is paramount for obtaining an adequate control of blood pressure.
In addition to the usual difficulties of the adherence to the medical treatment (financial difficulties, noxious effects of the medication, difficulties in accessing the health system, inadequacy of the medical-patient relation), additional characteristic factors of hypertension, such as the usual nonexistence of symptoms in the first 15 to 20 years and the chronicity of the disease, exist.
The interface between efficacy and effectiveness is particularly critical in the treatment of systemic hypertension. Effectiveness, which is evaluated in the actual conditions of treatment, shows unsatisfactory levels of blood pressure control. Much more important than the medical management, which sometimes is a little aggressive, the patient's adherence determines the success of treatment.
A high percentage of dropout of the ambulatory follow-up was identified in our cohort. In addition to several factors inherent to the disease that may explain this fact, we may also cite the great variety in geographical origin of the patients assisted, because at least 35% of them live in cities other than Porto Alegre.
Even though a loss of 163 patients occurred due to lack of information about certain characteristics, in the multivariate analysis these patients were distributed in a similar manner between the groups of dropout and follow-up.
Smoking seemed to be associated with dropout of medical follow-up, and was also associated with a lower preoccupation with disease prevention and health promotion. In the same way, patients with a recent diagnosis of hypertension did not properly undergo the medical follow-up, perhaps because most of them were previously healthy and asymptomatic. A lower educational level, indicating the social and economical profile, was also related to a high frequency of dropout.
We believe that priority measures should be directed towards the risk group identified in this cohort comprising patients with a lower educational level, a recent diagnosis, and smokers, in order to guarantee adherence to treatment. Medical assistance closer to their dwellings, constitution of support groups, and an active search for those missing the visits may extend the benefit of interventions for controlling hypertension to a larger number of patients.
